Apimeds Pharmaceuticals US
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell APUS and other ETFs, options, and stocks.About APUS
Apimeds Pharmaceuticals US, Inc. is a clinical stage biopharmaceutical company that engages in the development of Apitox, an intradermally administered bee venom-based toxin. It primarily focuses on developing innovative therapies for inflammation and pain management in knee osteoarthritis (OA) and, to a lesser extent, multiple sclerosis (MS).
CEOVinod Menon
CEOVinod Menon
Employees2
Employees2
HeadquartersMatawan, New Jersey
HeadquartersMatawan, New Jersey
Founded2020
Founded2020
Employees2
Employees2
APUS Key Statistics
Market cap26.35M
Market cap26.35M
Price-Earnings ratio-4.83
Price-Earnings ratio-4.83
Dividend yield—
Dividend yield—
Average volume136.81K
Average volume136.81K
High today$2.24
High today$2.24
Low today$2.09
Low today$2.09
Open price$2.21
Open price$2.21
Volume66.40K
Volume66.40K
52 Week high$4.03
52 Week high$4.03
52 Week low$1.37
52 Week low$1.37
Stock Snapshot
With a market cap of 26.35M, Apimeds Pharmaceuticals US(APUS) trades at $2.16. The stock has a price-to-earnings ratio of -4.83.
During the trading session on 2025-12-12, Apimeds Pharmaceuticals US(APUS) shares reached a daily high of $2.24 and a low of $2.09. At a current price of $2.16, the stock is +3.3% higher than the low and still -3.6% under the high.
Trading volume for Apimeds Pharmaceuticals US(APUS) stock has reached 66.4K, versus its average volume of 136.81K.
Over the past 52 weeks, Apimeds Pharmaceuticals US(APUS) stock has traded between a high of $4.03 and a low of $1.37.
Over the past 52 weeks, Apimeds Pharmaceuticals US(APUS) stock has traded between a high of $4.03 and a low of $1.37.
People also own
Based on the portfolios of people who own APUS. This list is generated using Robinhood data, and it’s not a recommendation.